Transport vials filled with human feces for stool testing. Yellow and blue tops for parasite testing, red top for stool cultures and the white top was provided by the patient with the sample.
Purpose
diagnose if medical condition is present
A stool test is a medical diagnostic technique that involves the collection and analysis of fecal matter. Microbial analysis (culturing), microscopy and chemical tests are among the tests performed on stool samples.
Collection
Stool samples should be sent to the laboratory as soon as possible after collection and should not be refrigerated prior to by the laboratory.[1]
Visual examination
The patient and/or health care worker in the office or at the bedside is able to make some important observations.
Color
Texture/consistency—formed
Classify type of feces (diagnostic triad for irritable bowel syndrome) based on Bristol stool scale
Cancers, and to a lesser extent, precancerous lesions, shed abnormal cells into the stool.[4] Cancers and precancerous lesions (polyps) that are ulcerated or rubbed by passing stool also may shed blood into the stool, which can be identified by a hemoglobin assay.[4]
A multi-target stool DNA test was approved in August 2014 by the FDA as a screening test for non-symptomatic, average-risk adults 50 years or older.[8] A 2017 study found this testing to be less cost effective compared to colonoscopy or fecal occult blood testing.[9] Three-year multi-target stool DNA test has been estimated to cost $11,313 per quality-adjusted life year (QALY) compared with no screening.[10]
Parasitic diseases such as ascariasis, hookworm, strongyloidiasis and whipworm can be diagnosed by examining stools under a microscope for the presence of worm larvae or eggs. Some bacterial diseases can be detected with a stool culture. Toxins from bacteria such as Clostridioides difficile ("C. diff.") can also be identified. Viruses such as rotavirus can also be found in stools.[11] Other stool tests involve the detection of antibiotic resistance as to guide appropriate therapy, e.g. Clarithromycin resistance of Helicobacter pylori represents a major challenge in eradication therapy but the responsible bacterial genomic markers can be detected in stool using PCR technology and thus can guide the prescription of the appropriate antibiotics to specific patients.[12]